Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes.

Our results demonstrate that expression-altering variants are found in a substantial fraction of cases and illustrate the yield of genomic risk assessments for a wide range of diseases across diverse populations.